Although anti-VEGFA therapy is not efficient in some patients and some individuals do not tolerate it, nowadays it is the only treatment for wet AMD that has consistently evidenced efficacy and is routinely used in a clinic setting. This evidence concerns the gene VEGFA and wet macular degeneration.